Radiotherapy combined with immunotherapy: the dawn of cancer treatment von Zhang, Zengfu, Liu, Xu, Chen, Dawei, Yu, Jinming

Volltext

Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review von Teng, Feifei, Meng, Xiangjiao, Kong, Li, Yu, Jinming

Volltext

Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy von Meng, Xiangjiao, Huang, Zhaoqin, Teng, Feifei, Xing, Ligang, Yu, Jinming

Volltext

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma von Wang, Xin, Guo, Gaochao, Guan, Hui, Yu, Yang, Lu, Jie, Yu, Jinming

Volltext

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors von Liu, Yang, Dong, Yinping, Kong, Li, Shi, Fang, Zhu, Hui, Yu, Jinming

Volltext

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges von Chen, Yu, Gao, Min, Huang, Zhaoqin, Yu, Jinming, Meng, Xiangjiao

Volltext

Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications von Teng, Feifei, Li, Min, Yu, Jinming

Volltext

Recent Development of pH-Responsive Polymers for Cancer Nanomedicine von Tang, Houliang, Zhao, Weilong, Yu, Jinming, Li, Yang, Zhao, Chao

Volltext

Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis von Liu, Jing, Dong, Min, Sun, Xiaorong, Li, Wenwu, Xing, Ligang, Yu, Jinming

Volltext

The landscape of bispecific T cell engager in cancer treatment von Zhou, Shujie, Liu, Mingguo, Ren, Fei, Meng, Xiangjiao, Yu, Jinming

Volltext

The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis von Xue, Song, Song, Ge, Yu, Jinming

Volltext

Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC von Li, Xue, Lian, Zhen, Wang, Shuai, Xing, Ligang, Yu, Jinming

Volltext

Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors von Wu, Leilei, Ke, Linping, Zhang, Zhenshan, Yu, Jinming, Meng, Xue

Volltext

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities von Wang, Bolin, Pei, Jinli, Xu, Shengnan, Liu, Jie, Yu, Jinming

Volltext

The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy von Jia, Wenxiao, Gao, Qianqian, Han, Anqin, Zhu, Hui, Yu, Jinming

Volltext

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy von Xue, Song, Hu, Man, Iyer, Veena, Yu, Jinming

Volltext

MiR‐216a‐3p inhibits colorectal cancer cell proliferation through direct targeting COX‐2 and ALOX5 von Wang, Dongxia, Li, Yuechun, Zhang, Chun, Li, Xianming, Yu, Jinming

Volltext

Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice von Chen, Yu, Pei, Yanqing, Luo, Jingyu, Huang, Zhaoqin, Yu, Jinming, Meng, Xiangjiao

Volltext

A good start of immunotherapy in esophageal cancer von Zhao, Qian, Yu, Jinming, Meng, Xue

Volltext

Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors von Li, Li, Chen, Xiaoyuan, Yu, Jinming, Yuan, Shuanghu

Volltext